Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carsten Bokemeyer

Showing results (511-520 of 664) with videos related to

Pageof 67
Sort By:
Leukemia & Lymphoma|May 17, 2017
Frondoside A induces AIF-associated caspase-independent apoptosis in Burkitt lymphoma cellsSergey A Dyshlovoy, Stefanie Rast, Jessica Hauschild, et al.
Cancer Immunology, Immunotherapy : CII|April 24, 2025
Expression of the TIGIT axis and the CD39/CD73 purinergic pathway in bone metastasis-derived immune cellsElias Brauneck, Leon-Gordian Leonhardt, Anne Marie Assemissen, et al.
American Journal of Hematology|September 8, 2011
Cancer-testis antigen expression and its epigenetic modulation in acute myeloid leukemiaDjordje Atanackovic, Tim Luetkens, Benjamin Kloth, et al.
Molecular Cancer Therapeutics|March 3, 2019
Nanobody Targeting of Epidermal Growth Factor Receptor (EGFR) Ectodomain Variants Overcomes Resistance to Therapeutic EGFR AntibodiesJoseph Tintelnot, Natalie Baum, Christoph Schultheiß, et al.
Oncology Reports|December 7, 2002
Limitations of tissue microarrays in the evaluation of focal alterations of bcl-2 and p53 in whole mount derived prostate tissuesAxel S Merseburger, Markus A Kuczyk, Jurgen Serth, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 25, 2010
Low level HER2 overexpression is associated with rapid tumor cell proliferation and poor prognosis in prostate cancerSarah Minner, Birte Jessen, Lars Stiedenroth, et al.
Journal of Proteome Research|March 20, 2012
Peroxiredoxins 3 and 4 are overexpressed in prostate cancer tissue and affect the proliferation of prostate cancer cells in vitroRamesh Ummanni, Frederico Barreto, Simone Venz, et al.
Blood|December 18, 2002
Telomere length in peripheral blood granulocytes reflects response to treatment with imatinib in patients with chronic myeloid leukemiaTim H Brümmendorf, Inci Ersöz, Ulrike Hartmann, et al.
Biomedicines|March 28, 2025
Functional Role of Fatty Acid Synthase for Signal Transduction in Core-Binding Factor Acute Myeloid Leukemia with an Activating c-Kit MutationRuimeng Zhuang, Bente Siebels, Konstantin Hoffer, et al.
Oncotarget|June 11, 2015
Epidermal growth factor receptor mutation mediates cross-resistance to panitumumab and cetuximab in gastrointestinal cancerFriederike Braig, Manuela März, Aneta Schieferdecker, et al.
Pageof 67

Showing results (511-520 of 664) with videos related to

Sort By:
Pageof 67
Leukemia & Lymphoma|May 17, 2017
Frondoside A induces AIF-associated caspase-independent apoptosis in Burkitt lymphoma cellsSergey A Dyshlovoy, Stefanie Rast, Jessica Hauschild, et al.
Cancer Immunology, Immunotherapy : CII|April 24, 2025
Expression of the TIGIT axis and the CD39/CD73 purinergic pathway in bone metastasis-derived immune cellsElias Brauneck, Leon-Gordian Leonhardt, Anne Marie Assemissen, et al.
American Journal of Hematology|September 8, 2011
Cancer-testis antigen expression and its epigenetic modulation in acute myeloid leukemiaDjordje Atanackovic, Tim Luetkens, Benjamin Kloth, et al.
Molecular Cancer Therapeutics|March 3, 2019
Nanobody Targeting of Epidermal Growth Factor Receptor (EGFR) Ectodomain Variants Overcomes Resistance to Therapeutic EGFR AntibodiesJoseph Tintelnot, Natalie Baum, Christoph Schultheiß, et al.
Oncology Reports|December 7, 2002
Limitations of tissue microarrays in the evaluation of focal alterations of bcl-2 and p53 in whole mount derived prostate tissuesAxel S Merseburger, Markus A Kuczyk, Jurgen Serth, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 25, 2010
Low level HER2 overexpression is associated with rapid tumor cell proliferation and poor prognosis in prostate cancerSarah Minner, Birte Jessen, Lars Stiedenroth, et al.
Journal of Proteome Research|March 20, 2012
Peroxiredoxins 3 and 4 are overexpressed in prostate cancer tissue and affect the proliferation of prostate cancer cells in vitroRamesh Ummanni, Frederico Barreto, Simone Venz, et al.
Blood|December 18, 2002
Telomere length in peripheral blood granulocytes reflects response to treatment with imatinib in patients with chronic myeloid leukemiaTim H Brümmendorf, Inci Ersöz, Ulrike Hartmann, et al.
Biomedicines|March 28, 2025
Functional Role of Fatty Acid Synthase for Signal Transduction in Core-Binding Factor Acute Myeloid Leukemia with an Activating c-Kit MutationRuimeng Zhuang, Bente Siebels, Konstantin Hoffer, et al.
Oncotarget|June 11, 2015
Epidermal growth factor receptor mutation mediates cross-resistance to panitumumab and cetuximab in gastrointestinal cancerFriederike Braig, Manuela März, Aneta Schieferdecker, et al.
Pageof 67